Free Trial

Teleflex (TFX) Competitors

Teleflex logo
$117.25 +1.05 (+0.90%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$117.22 -0.03 (-0.03%)
As of 07/25/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TFX vs. PODD, BAX, HOLX, MASI, GMED, ITGR, ATEC, ATRC, IART, and SRDX

Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), and Surmodics (SRDX). These companies are all part of the "health care equipment" industry.

Teleflex vs. Its Competitors

Teleflex (NYSE:TFX) and Insulet (NASDAQ:PODD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

In the previous week, Insulet had 6 more articles in the media than Teleflex. MarketBeat recorded 17 mentions for Insulet and 11 mentions for Teleflex. Insulet's average media sentiment score of 1.49 beat Teleflex's score of 1.00 indicating that Insulet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Insulet
14 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Insulet has a net margin of 18.29% compared to Teleflex's net margin of 4.96%. Insulet's return on equity of 22.25% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex4.96% 14.73% 8.79%
Insulet 18.29%22.25%8.29%

Teleflex has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Insulet has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

Teleflex currently has a consensus target price of $159.63, suggesting a potential upside of 36.14%. Insulet has a consensus target price of $321.00, suggesting a potential upside of 10.61%. Given Teleflex's higher possible upside, analysts clearly believe Teleflex is more favorable than Insulet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.09
Insulet
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

95.6% of Teleflex shares are held by institutional investors. 1.4% of Teleflex shares are held by insiders. Comparatively, 0.4% of Insulet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Insulet has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$3.05B1.70$69.68M$3.1736.99
Insulet$2.20B9.29$418.30M$5.5652.20

Summary

Insulet beats Teleflex on 11 of the 16 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFX vs. The Competition

MetricTeleflexMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$5.13B$6.85B$5.69B$21.10B
Dividend Yield1.17%1.27%4.58%3.59%
P/E Ratio36.9925.4528.1028.44
Price / Sales1.7064.09432.4458.59
Price / Cash4.5820.5536.2222.92
Price / Book1.274.758.664.69
Net Income$69.68M$176.14M$3.25B$995.51M
7 Day Performance5.46%2.92%4.23%1.65%
1 Month Performance-1.84%3.23%10.52%4.54%
1 Year Performance-46.78%7.28%34.41%9.99%

Teleflex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFX
Teleflex
4.8673 of 5 stars
$117.25
+0.9%
$159.63
+36.1%
-47.3%$5.13B$3.05B36.9914,100Positive News
Upcoming Earnings
PODD
Insulet
4.6055 of 5 stars
$289.32
-2.7%
$321.00
+10.9%
+52.0%$20.36B$2.07B52.043,900Positive News
BAX
Baxter International
4.2991 of 5 stars
$28.71
-3.3%
$36.50
+27.1%
-16.7%$14.73B$10.64B-26.1038,000Upcoming Earnings
HOLX
Hologic
4.7289 of 5 stars
$65.72
-1.7%
$78.75
+19.8%
-14.6%$14.65B$4.03B27.737,063Positive News
Upcoming Earnings
Analyst Revision
MASI
Masimo
4.0208 of 5 stars
$162.99
-2.0%
$191.60
+17.6%
+50.0%$8.84B$2.09B-17.775,600
GMED
Globus Medical
4.9593 of 5 stars
$57.09
-1.2%
$94.00
+64.7%
-24.1%$7.73B$2.52B42.605,300News Coverage
Analyst Forecast
Analyst Revision
ITGR
Integer
3.3848 of 5 stars
$119.73
-1.7%
$145.00
+21.1%
-6.5%$4.19B$1.72B56.7411,000Trending News
Earnings Report
Analyst Forecast
ATEC
Alphatec
3.9384 of 5 stars
$10.99
-5.1%
$17.89
+62.8%
-0.5%$1.61B$611.56M-9.56700News Coverage
Positive News
Upcoming Earnings
ATRC
AtriCure
3.4535 of 5 stars
$30.72
-4.2%
$50.67
+64.9%
+33.9%$1.52B$465.31M-37.931,300News Coverage
Upcoming Earnings
IART
Integra LifeSciences
4.1375 of 5 stars
$12.59
-4.4%
$18.63
+47.9%
-58.4%$978.39M$1.61B-33.134,396News Coverage
Upcoming Earnings
SRDX
Surmodics
3.9682 of 5 stars
$30.87
-0.5%
$43.00
+39.3%
-13.4%$441.41M$126.08M-22.21450News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NYSE:TFX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners